(Q36410784)

English

MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

1 reference

Europe PubMed Central

0 references

MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

author name string

Andy C Parrott

1

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

language of work or name

0 references

publication date

1 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Journal of Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

147-163

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Patterns of simultaneous polysubstance use in Canadian rave attendees

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

The role of an international nightlife resort in the proliferation of recreational drugs.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Memory impairment in abstinent MDMA ("Ecstasy") users.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Understanding reasons for drug use amongst young people: a functional perspective

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Differences Between Ecstasy-Using and Nonusing Methamphetamine Users

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Brain hyperthermia induced by MDMA (ecstasy): modulation by environmental conditions

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Subjective reports on the effects of the MDMA ('ecstasy') experience in humans.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Altered states: the clinical effects of Ecstasy.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

The content of ecstasy tablets: implications for the study of their long-term effects.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): a stressor on the immune system

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Heat increases 3,4-methylenedioxymethamphetamine self-administration and social effects in rats.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

‘Ecstasy’ Psychosis and Flashbacks

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

The relative contributions of ecstasy and cannabis to cognitive impairment

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Electrophysiological evidence of serotonergic impairment in long-term MDMA ("ecstasy") users

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Therapeutic potential of cannabinoids in CNS disease

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") but not by fenfluramine.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

A Clinical Plan for MDMA (Ecstasy) in the Treatment of Posttraumatic Stress Disorder (PTSD): Partnering with the FDA

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

The psychological and physiological effects of MDMA on normal volunteers.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Reasoning deficits in ecstasy (MDMA) polydrug users

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography study

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Hypothalamic–pituitary–adrenal axis responses to stress in subjects with 3,4-methylenedioxy-methamphetamine (‘ecstasy’) use history: correlation with dopamine receptor sensitivity

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Neuroendocrine abnormalities in recreational ecstasy (MDMA) users: is it ecstasy or cannabis?

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMA.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Cannabinoids and neuroprotection

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Adverse effects of cannabis

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

'Weddings, parties, anythingellipsis', a qualitative analysis of ecstasy use in Perth, Western Australia

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Self-rated everyday and prospective memory abilities of cigarette smokers and non-smokers: a web-based study

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Preliminary evidence of hippocampal dysfunction in adolescent MDMA ("ecstasy") users: possible relationship to neurotoxic effects

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Ecstasy (MDMA) dependence.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Amnesic syndrome and severe ataxia following the recreational use of 3,4-methylene-dioxymethamphetamine (MDMA, 'ecstasy') and other substances.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Psychobiological risk factors for vulnerability to psychostimulants in human adolescents and animal models

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Mental disorders in ecstasy users: a prospective-longitudinal investigation

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Gender differences in the subjective effects of MDMA.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Effects of alcohol on subjective ratings of prospective and everyday memory deficits

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Biological basis of sex differences in drug abuse: preclinical and clinical studies

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

"Partying" hard: party style, motives for and effects of MDMA use at rave parties

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Chronic MDMA (ecstasy) use, cognition and mood.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Long term psychiatric and cognitive effects of MDMA use.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Event-related potentials (ERPs) in ecstasy (MDMA) users during a visual oddball task.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Diathesis-stress theories in the context of life stress research: implications for the depressive disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Memory deficits associated with recreational use of "ecstasy" (MDMA).

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Ecstasy (MDMA): a review of its possible persistent psychological effects

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA ("Ecstasy") in rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Methamphetamine toxicity in mice is potentiated by exposure to loud music.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Does cigarette smoking cause stress?

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Human research on MDMA (3,4-methylene- dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Cigarette-derived nicotine is not a medicine

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Ecstasy and new patterns of drug use: a normal population study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Neuropsychological performance in long-term cannabis users

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Prepulse inhibition and habituation of acoustic startle response in male MDMA ('ecstasy') users, cannabis users, and healthy controls

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

MDMA on the Street: Analysis Anonymous®

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Experimental studies on 3,4-methylenedioxymethamphetamine (MDA, "ecstasy") and its potential to damage brain serotonin neurons

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Patterns of recreational drug use at dance events in Edinburgh, Scotland

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Impaired perception of self-motion (heading) in abstinent ecstasy and marijuana users

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Cognitive performance amongst recreational users of "ecstasy".

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Relationship between ecstasy use and depression: a study controlling for poly-drug use.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Association of a functional polymorphism in the serotonin transporter gene with abnormal emotional processing in ecstasy users

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Potential human neurotoxicity of MDMA ('Ecstasy'): subjective self-reports, evidence from an Italian drug addiction centre and clinical case studies

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

MDMA ("ecstasy") abuse: psychopathological features and craving for chocolate: a case series

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994-2003).

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Is the use of ecstasy and hallucinogens increasing? Results from a community study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

MDMA (Ecstasy) controls in concert a group of genes involved in GABA neurotransmission

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

The impact of regular ecstasy use on memory function.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Psychosocial profiles of older adolescent MDMA users.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Persistent neuropsychological problems after 7 years of abstinence from recreational Ecstasy (MDMA): a case study

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Psychiatric disorders in Ecstasy (MDMA) users: a literature review focusing on personal predisposition and drug history

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Monitoring synthetic drug markets, trends, and public health

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Increasing MDMA use among college students: results of a national survey

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Self-reported psychopathology in polydrug users.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

The use of drugs within the techno party scene in European metropolitan cities

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Acute, sub‐acute and long‐term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Quitting ecstasy: an investigation of why people stop taking the drug and their subsequent mental health

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Cognitive performance and serotonergic function in users of ecstasy.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Acute Psychological and Neurophysiological Effects of MDMA in Humans

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Impaired executive function in male MDMA ("ecstasy") users

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Working memory deficits in current and previous users of MDMA ('ecstasy').

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Visuospatial memory impairments in users of MDMA ('ecstasy').

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Alcohol and drug use in UK university students.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Adverse effects of stimulant drugs in a community sample of drug users.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

It's a rave new world: estimating the prevalence and perceived harm of ecstasy and other drug use among club rave attendees

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Effect of ecstasy use on neuropsychological function: a study in Hong Kong

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Co-administration of THC and MDMA ('ecstasy') synergistically disrupts memory in rats.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Memory impairment in abstinent MDMA ("Ecstasy") users: a longitudinal investigation

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

3,4-Methylenedioxymethamphetamine (MDMA) abuse may cause oxidative stress and potential free radical damage

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063268

21 January 2018

Identifiers

10.1177/0269881106063268

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36410784&oldid=1629985920"